Why can we see our narrowband UVB lights? - 15/04/20
Funding sources: None. |
|
Conflicts of interest: David E. Cohen has declared the following financial interests: Consultant and Honorarium: Ferndale Laboratories, Asana, Medimetriks, Cutanea, Ferrer, Celgene, Dermavant, SFJ, and FIDE (FIDE receives industry sponsorship from AbbVie, Almirall, Amgen, Bausch and Lomb, Bristol-Myers Squibb, Celgene, Dermavant, Dermira, Janssen, Kyowa Hakko Kirin, LEO, Lilly, Novartis, Ortho Dermatologics, Pfizer, Sanofi Genzyme, Sun Pharma, UCB, and Valeant); Stock or stock options: Dermira, Medimetriks, Brickell Biotech, and Kadmon; and Board of Directors: Dermira and Kadmon. No other conflicts of interest were disclosed. |
|
IRB approval status: Not applicable. |
|
Reprints not available from the authors. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?